ArticleHepatology (Baltimore, Md.)2017

Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort.

Loreta A Kondili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.